Target intelligence / Profile preview

Calcineurin like EF-hand protein 2 (CHP2)

Target
CHP2
Molecular classification
EF-hand calcium-binding protein, Regulator of Na+/H+ exchanger (SLC9A/NHE family), Calcineurin homologous protein subfamily, Other
01

Overview

Calcineurin like EF-hand protein 2 (CHP2) is a small, EF-hand calcium-binding protein that serves as an essential cofactor in regulating cellular pH by controlling the activity of plasma membrane Na+/H+ exchangers, particularly the NHE1 isoform[1][3]. CHP2 is structurally characterized by four EF-hand motifs (two that bind calcium), a myristoylation signal, and a conserved nuclear export signal[1]. It shares substantial sequence similarity with calcineurin B, the regulatory subunit of the protein phosphatase calcineurin, and can stimulate calcineurin phosphatase activity under certain conditions[3]. CHP2 is expressed in various tissues, is implicated in proliferation and tumor growth, and was first identified as a tumor-associated antigen. Although not a classical pharmacological target, CHP2's modulation of ion transport and cell signaling pathways makes it significant for cell homeostasis and disease biology[1][3].

Other names
CHP2Hepatocellular carcinoma-associated antigen 520Calcineurin B homologous protein 2Calcineurin homologous protein 2
02

Mechanism of action

Not applicable—no drugs directly target CHP2. Its physiological action involves: - Modulating Na+/H+ exchanger activity (not as a drug target but via protein-protein interaction) - Possibly potentiating calcineurin phosphatase activity (protein-level effect, not drug-induced)

03

Biological functions

Regulation of plasma membrane Na+/H+ exchanger activityControl of cellular pHStimulation of calcineurin phosphatase activity (in some contexts)Regulation of cell proliferation and tumor growthCarrier vesicle trafficking and gene transcription (for the CHP subfamily in general)
04

Disease associations

CancerNeurodegenerative diseaseOther
05

Safety considerations

Not directly connected to known drug toxicity or safety concerns.Theoretical concerns include effects on cellular pH, cellular proliferation, or potential oncogenicity if dysregulated, as suggested by tumor association

Beyond the preview

Go deeper on Calcineurin like EF-hand protein 2 (CHP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcineurin like EF-hand protein 2 (CHP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call